发明名称 Prion-free collagen and collagen-derived products and implants for multiple biomedical applications; methods of making thereof
摘要 The use of collagen as a biomedical implant raises safety issues towards viruses and prions. The physicochemical changes and the in vitro and in vivo biocompatibility of collagen treated with heat, and by formic acid (FA), trifluoroacetic acid (TFA), tetrafluoroethanol (TFE) and hexafluoroiso-propanol (HFIP) were investigated. FA and TFA resulted in extensive depurination of nucleic acids while HFIP and TFE did so to a lesser degree. The molecules of FA, and most importantly of TFA, remained within collagen. Although these two acids induced modification in the secondary structure of collagen, resistance to collagenase was not affected and, in vitro, cell growth was not impaired. Severe dehydrothermal treatment, for example 110° C. for 1-3 days under high vacuum, also succeeded in removing completely nucleic acids. Since this treatment also leads to slight cross-linking, it could be advantageously used to eliminate prion and to stabilize gelatin products. Finally, prolonged treatment with TFA provides a transparent collagen, which transparency is further enhanced by adding glycosaminoglycans or proteoglycans, particularly hyaluronic acid. All the above treatments could offer a safe and biocompatible collagen-derived material for diverse biomedical uses, by providing a virus or prion-free product.
申请公布号 US6197935(B1) 申请公布日期 2001.03.06
申请号 US19980117378 申请日期 1998.09.29
申请人 发明人
分类号 A61K9/48;A61F2/00;A61L2/00;A61L2/18;A61L15/64;A61L27/00;A61L27/24;C07K1/14;C07K14/78;(IPC1-7):A61K38/17;A61L15/00 主分类号 A61K9/48
代理机构 代理人
主权项
地址